Selecting the Best Liver Transplant Surgeons and Hospitals in India

Author:- Dr. Dheeraj Bojwani Date Created:- 06-08-2026

Among every organ used in living donor transplantation, the liver is unique: both the donor's remaining portion and the recipient's transplanted portion regenerate toward near-full original volume within weeks. This genuinely remarkable biological fact is often, understandably, the detail families remember most clearly from an initial consultation. It should not be the only one. Published transplant literature places living liver donation at meaningfully higher donor risk than living kidney donation, and a family that lets the regeneration story stand in for a full understanding of that risk is not as informed as they deserve to be. This guide sits alongside this series' kidney transplant guide in one important respect, both involve a healthy donor accepting real risk on behalf of someone they love, and diverges from it in another: the specific biology, the specific risk profile, and the specific technical demands on the surgeon are genuinely different for a liver.

Key Takeaways

• Living donor liver transplantation has a unique biological advantage: both the donor's remaining liver and the recipient's transplanted portion regenerate toward near-full original volume within weeks. However, the guide repeatedly warns that regeneration should never be used to minimise the real risks carried by a healthy donor.
• Living liver donation carries a meaningfully higher donor risk than living kidney donation. The guide cites published donor mortality ranges of approximately 0.1–0.5% for living liver donation, compared with roughly 0.03% for living kidney donation.
• The donor should undergo a separate and independent evaluation, rather than being treated simply as part of the recipient's treatment pathway.
• If the graft is too small, the recipient can develop small-for-size syndrome, in which the transplanted liver struggles to meet the body's metabolic demand.
• At the same time, taking a larger graft to benefit the recipient leaves the donor with a smaller liver remnant. Graft-size planning is therefore a genuine two-patient calculation, balancing recipient requirements against donor safety.
• Compared with kidney transplantation, liver transplant places slightly greater relative weight on the individual surgeon.
• Patients should ask for the programme's own donor complication and mortality data, not only recipient survival figures.
• The hospital should provide its own graft-survival and patient-survival data at one year and beyond. Broad statements such as “high success rate” are less useful than specific, tracked outcomes.
• For Nigerian families, the guide links much of the country's transplant need to chronic viral hepatitis, which can progress over years to cirrhosis or liver cancer.
• The four major warning signs identified are: donor risk minimised through the regeneration story, no specific graft-size discussion, vague donor or recipient outcome data, and a donor evaluation that feels rushed or pressured.

Quick Facts

Topic

Selecting Liver Transplant Surgeons and Hospitals

Country

India

Intended Audience

Nigerian Patients and Families

Primary Specialty

Liver Transplantation and Hepatobiliary Surgery

Primary Procedure

Living Donor Liver Transplant

Unique Biological Feature

Liver Regeneration

Living Liver Donor Mortality Range Mentioned

Approximately 0.1–0.5%

Donor Evaluation

Must Be Independent

Major Technical Planning Issue

Graft Size

Major Graft-Size Complication

Small-for-Size Syndrome

Surgeon vs Hospital Weighting

Slightly More Weight to Surgeon

Main Decision Principle

Protect the Donor as Seriously as the Recipient While Choosing a Technically Experienced Transplant Programme

Author/Advisor

Dr. Dheeraj Bojwani

Experience

24 Years

In Brief

Selecting a liver transplant programme in India requires Nigerian families to evaluate both surgical precision and the hospital's transplant infrastructure. Living donor liver transplantation is unique because both the donor's remaining liver and the recipient's graft regenerate toward near-full volume over approximately 8–12 weeks, but this does not eliminate donor risk. Published literature cited in the guide places living liver-donor mortality at roughly 0.1–0.5%, higher than for living kidney donation. Graft-size planning is also critical because a graft that is too small can lead to small-for-size syndrome, while taking too much liver increases risk to the donor. For this reason, the guide gives the individual surgeon slightly more weight than the hospital, while still requiring strong ICU, hepatology, vascular and biliary complication management.

START HERE

The organ that grows itself back

Understanding how liver regeneration actually works is worth a moment, since it shapes the entire donor conversation.

Both the donor's remaining liver and the transplanted portion regenerate toward full size within weeks.

This is genuinely one of the most remarkable facts in transplant medicine, and it is real, not marketing language. It is also, precisely because it sounds so reassuring, a detail that can be used to soften a conversation that deserves to stay clear-eyed. A donor's liver growing back does not mean the surgery itself, or the recovery period before regeneration completes, carries no risk. The weeks between surgery and full regeneration are precisely when a donor is at their most vulnerable, and this is the window a thorough evaluation and recovery plan needs to protect.

THE HONEST NUMBER

Regeneration does not mean the surgery is risk-free

This is worth stating plainly, since it is genuinely easy for a hopeful family to gloss over in the excitement of finding a willing donor.

Figures reflect published ranges across transplant centres; ask any specific programme for its own donor outcome data directly.

None of this means living liver donation is unreasonably dangerous; the overwhelming majority of donors recover fully and go on to live entirely normal lives, and the operation has been performed safely at real scale for decades. It means the decision deserves the same honest weighing any major surgery deserves, and a programme that leans heavily on the regeneration story while glossing over these numbers is not giving a donor the full picture they are entitled to before consenting. A donor who understands the real numbers and still chooses to proceed is making a genuinely informed decision; a donor reassured mainly by the regeneration story is not.

THE BALANCE

Slightly closer to even than kidney transplant

Partitioning a liver for donation, and reconstructing the complex network of blood vessels and bile ducts in the recipient, is technically more demanding than a standard kidney transplant, and this shows up in how the surgeon-hospital balance shifts for this specific procedure.

Partitioning and reconstructing a liver is technically more demanding than a kidney transplant.

This is a more even split than kidney transplant, where the hospital's long-term programme infrastructure carries the larger share. For liver transplant, the technical execution during surgery itself, avoiding vascular or biliary complications that can be difficult to fully correct afterward, genuinely tips the balance slightly toward the individual surgeon, even though the hospital's hepatology and ICU capacity remains essential for both donor and recipient recovery. A biliary leak or a vascular complication caught and corrected within hours of surgery often has a very different outcome than one discovered days later, which is precisely why both the surgeon's initial technique and the hospital's early monitoring systems matter so much together.

THE VETTING CONVERSATION What to actually ask

Questions about the donor

1. What is your programme's own donor complication and mortality data, specifically? A precise, comfortable answer suggests real, tracked experience.
2. How is graft size determined and matched to my specific case? This should be a specific, imaging-based answer, not a general estimate.
3. Is the donor evaluated independently, separate from the recipient's care team? This protects against pressure influencing a medical judgement.
4. What does donor recovery actually look like, week by week, before regeneration completes? A thorough answer discusses the real recovery period honestly.

Questions about the hospital

1. What is the hospital's own graft and patient survival data, at one year and beyond? Specific, tracked figures matter more than general reputation.
2. What ICU and hepatology support exists for managing early post-transplant complications? This is where many serious issues are actually caught and managed.
3. What is the immunosuppression protocol, and the long-term monitoring plan? This affects the recipient's life for years after returning home.
4. What happens if small-for-size syndrome or a vascular complication occurs? A programme with real experience can describe this clearly.

NIGERIA-SPECIFIC CONSIDERATIONS

Why this decision often starts years earlier

Much of the liver disease that eventually leads to transplant need in Nigeria traces back to chronic viral hepatitis, a burden this series has documented as among the highest in the world, layered onto the country's own limited domestic transplant capacity. This means the honest, informed donor conversation described in this guide often arrives at a moment already shaped by years of prior disease progression, making it even more important to get right rather than rush through under pressure. A family that has already spent years managing a loved one's declining liver health can understandably feel enormous urgency once a donor is identified; that urgency is exactly why a deliberate, unhurried evaluation process matters most, not least.

For families identifying a willing donor within Nigeria, the same standard applies regardless of where surgery ultimately takes place: independent donor evaluation, honest risk discussion, and careful graft size planning are not steps to shortcut because a country's healthcare system is unfamiliar, but a baseline every family deserves to insist on everywhere.

Four warning signs worth taking seriously

• Donor risk minimised by leaning heavily on the regeneration story. Regeneration is real, but it does not eliminate real surgical risk.
• No specific discussion of graft size planning for your particular case. This is a genuine, case-specific technical question, not a formality.
• Vague answers about the programme's own donor and recipient outcome data. A confident, experienced programme tracks and shares this.
• A donor evaluation that feels rushed or pressured by family circumstances. This deserves independence and enough time to be genuine.

A practical order of operations

1. Identify a potential living donor and begin independent, unhurried donor evaluation.
2. Ask directly about the programme's specific donor complication and mortality data.
3. Confirm graft size planning is being done specifically for your case, based on imaging.
4. Ask the surgeon-side and hospital-side questions above before committing to a programme.
5. Travel, surgery for both donor and recipient, and a supervised recovery period through the regeneration window.
6. Establish a lifelong monitoring relationship with a Nigerian hepatologist before returning home.

A closing word

The liver's ability to regenerate is one of the more hopeful facts in all of transplant medicine, and it deserves to be shared honestly with every family considering this path. What it should never do is replace a clear, unhurried conversation about the real risk a healthy donor is choosing to accept, or the technical precision graft size planning and surgical reconstruction genuinely require. In twenty-four years of this work, the families who navigate this best hold both truths at once: that this is a remarkable, often life-saving procedure, and that the person donating deserves the same rigorous, honest evaluation as the person receiving. A liver grows back over weeks. The trust built through an honest donor conversation is what makes those weeks worth the risk, and it is a trust worth insisting on from the very first consultation, not assuming will simply be there when it matters most.

Sources

• 🌐 American Liver Foundation — Living donor liver transplant, patient information
• 🌐 American Society of Transplant Surgeons — Living donor risk and outcomes, published guidance
• 🌐 NHS (UK) — Liver transplant: overview – nhs.uk
• 🌐 Liver Transplantation. StatPearls, NCBI Bookshelf, 2026
• 🌐 High Commission of India, Abuja — Medical and Medical Attendant Visa requirements

Frequently Asked Questions

Does the liver really grow back after living donation?

Yes. Both the donor's remaining liver and the recipient's transplanted portion regenerate toward near-full original volume within approximately eight to twelve weeks, a genuinely unique property among transplantable organs.

Does liver regeneration mean living donation is low risk?

No. Regeneration is real, but the surgery still carries genuine risk. The guide cites living liver donor mortality of roughly 0.1–0.5%, higher than the approximate 0.03% cited for living kidney donation.

Why must the liver donor be evaluated independently?

Because the donor is a healthy person accepting major surgery for someone else. Independent assessment helps protect the donor from medical risk and from family pressure influencing the decision.

What is small-for-size syndrome?

It occurs when the transplanted liver portion is too small relative to the recipient's body size, leading to graft dysfunction. Careful pre-operative graft size planning is essential to avoiding it.

Why is graft-size planning so important?

The surgeon must balance two competing needs: provide enough liver to the recipient while leaving enough behind for the donor to recover safely. This requires patient-specific imaging and calculation.

Why does the surgeon matter slightly more than the hospital in liver transplantation?

Liver partitioning and reconstruction of multiple blood vessels and bile ducts are technically demanding. Errors can lead to serious biliary or vascular complications, so individual surgical experience carries unusual weight.

What should Nigerian families ask the transplant hospital?

Ask for one-year and longer graft and patient survival, ICU and hepatology support, the immunosuppression plan and how the centre handles small-for-size syndrome, biliary leaks and vascular complications.

What should families ask specifically about the donor?

Ask for the programme's donor complication and mortality data, how graft size is calculated, whether donor evaluation is independent and what recovery looks like during the regeneration period.

What are the major warning signs when choosing a liver transplant programme?

Warning signs include minimising donor risk because “the liver grows back,” failing to discuss graft size, giving vague outcome data or rushing the donor evaluation because the recipient's condition is urgent.

What follow-up is needed after returning to Nigeria?

The recipient requires lifelong immunosuppression, liver-function monitoring and ongoing specialist review. The guide recommends establishing a relationship with a Nigerian hepatologist before returning home rather than arranging follow-up afterward.

Is living liver donation as safe as living kidney donation?

No. Published literature places liver donation at meaningfully higher donor risk, with mortality risk around 0.1 to 0.5 percent compared to roughly 0.03 percent for kidney donors, and a higher rate of mostly minor complications.

Why does the surgeon matter slightly more than the hospital here?

Partitioning a liver and reconstructing the complex vessel and bile duct connections is technically more demanding than a kidney transplant, giving the surgeon's skill slightly more weight, though hospital infrastructure still matters substantially.

What is a realistic red flag when choosing a programme?

Downplaying donor risk by emphasising regeneration alone, no discussion of graft size planning, or an inability to describe outcome data, are all genuine warning signs.

Page Summary

This guide explains how Nigerian families should evaluate liver transplant surgeons and hospitals in India, beginning with a fact that reassures too easily: the liver regenerates, in both the donor and the recipient, over roughly 8–12 weeks. That does not make living donation risk-free — donor mortality runs at about 0.1–0.5%, against roughly 0.03% for a kidney — so the donor needs an independent evaluation rather than a place inside the recipient's treatment plan. Graft size is the second technical question: large enough for the recipient, small enough to leave the donor safe. Because dividing the liver and reconstructing vessels and bile ducts is demanding, the surgeon carries slightly more weight here than in kidney transplantation — but only alongside a hospital that can catch a complication early.

Citation Block

Topic	Information
Topic Information	Details
Topic	Selecting the Best Liver Transplant Surgeons and Hospitals in India
Procedure	Living Donor Liver Transplant
Country	India
Intended Audience	Nigerian Patients and Families
Primary Specialty	Liver Transplant and Hepatobiliary Surgery
Unique Biological Feature	Donor and Recipient Liver Regeneration
Approximate Regeneration Window	8–12 Weeks
Living Liver Donor Mortality Range Mentioned	Approximately 0.1–0.5%
Key Donor Requirement	Independent Medical Evaluation
Major Technical Requirement	Patient-Specific Graft-Size Planning
Main Decision Principle	Balance Donor Safety, Graft Size, Surgical Skill and Hospital Systems